Derek Dowell News
FTC's antitrust lawsuit against Endo targets reverse payments
PHILADELPHIA - The Federal Trade Commission (FTC) thinks Endo Pharmaceuticals and other drug companies are violating antitrust laws when they pay other companies to delay bringing generic versions of their products to market.